Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
26.7%
% of FBT's 31 holdings also in IBRN
19.5%
% of IBRN's 55 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
ACADIA PHARMACEUTICALS INC | 3.9% | 4.4% | 3.9% |
 |
ARGENX SE ADR | 3.8% | 4.5% | 3.8% |
|
NEUROCRINE BIOSCIENCES INC | 3.7% | 4.3% | 3.7% |
|
INTRA-CELLULAR THERAPIES INC | 3.7% | 4.6% | 3.7% |
|
CATALYST PHARMACEUTICAL PART | 3.6% | 4.4% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to IBRN
|
EXELIXIS INC | 4.5% |
|
NATERA INC | 4.3% |
|
CORCEPT THERAPEUTICS INC | 4.1% |
|
REPLIGEN CORP | 3.8% |
|
GILEAD SCIENCES INC | 3.6% |
|
WATERS CORP | 3.6% |
|
INCYTE CORP | 3.5% |
|
UNITED THERAPEUTICS CORP | 3.4% |
 |
BIONTECH SE SPONSORED ADR | 3.4% |
|
ILLUMINA INC | 3.3% |
FBT Underweight Relative to IBRN
|
PTC THERAPEUTICS INC | -6.0% |
|
SCHOLAR ROCK HOLDING CORP. | -5.5% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.8% |
|
SUPERNUS PHARMACEUTICALS INC | -3.8% |
|
EDGEWISE THERAPEUTICS, INC. | -3.2% |
|
DYNE THERAPEUTICS INC | -3.2% |
|
INTEGRA LIFESCIENCES HOLDING | -3.1% |
|
ANAVEX LIFE SCIENCES CORP. | -1.4% |
 |
PROTHENA CORP PLC | -1.2% |
|
AXOGEN, INC. | -1.2% |